Home › Funds › Bellevue Group AG › GILD

Bellevue Group AG position in GILD

GILEAD SCIENCES INC · Health Care

Bellevue Group AG reported holding 2,158,772 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$272.7M, representing 5.74% of its reported portfolio and ranking #4 among its reported holdings. Bellevue Group AG has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.16M sh
Reported value held$272.74M
Portfolio Weight5.74%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's GILD position evolved

Bellevue Group AG first disclosed a stake in GILD in Q3 2023 at 107,350 shares (US$8.0M). The position peaked in Q2 2026 at 2,158,772 shares, worth US$272.7M. Across 12 filings, Bellevue Group AG increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,158,772 shares valued at US$272.7M — an increase of 988,893 shares quarter over quarter.. Notable position changes include a 52% trim in Q4 2023 (shares fell 9% over the following quarter), a 2118% increase in Q1 2026 (shares fell 10% over the following quarter), a 85% increase in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 107.35K $8.04M New
Q4 2023 51.30K $4.16M Reduce
Q1 2024 33.30K $2.44M Reduce
Q2 2024 38.93K $2.67M Add
Q3 2024 46.03K $3.86M Add
Q4 2024 48.43K $4.47M Add
Q1 2025 55.02K $6.17M Add
Q2 2025 51.42K $5.70M Reduce
Q3 2025 49.89K $5.54M Reduce
Q4 2025 52.75K $6.47M Add
Q1 2026 1.17M $163.05M Add
Q2 2026 2.16M $272.74M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Bellevue Group AG held GILD?

Bellevue Group AG has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Bellevue Group AG's current position in GILD?

As of Q2 2026, Bellevue Group AG holds 2.16M shares of GILD (GILEAD SCIENCES INC), valued at $272.74M, representing 5.74% of its reported portfolio and ranking #4.

Has Bellevue Group AG been buying or selling GILD?

In the latest 13F filing (Q2 2026), Bellevue Group AG increased its position in GILD. The position peaked in Q2 2026 at 2.16M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.